APOE-ε4 is not associated with cognitive impairment in relapsing

Abstract

The objective of this article was to assess the association between apolipoprotein E (APOE)-ε4 and cognitive impairment (CI) in relapsing—remitting multiple sclerosis (RRMS). The APOE genotype was assessed in 85 RRMS cases (58 females, mean age 43 ± 8.4 years, mean disease duration 15.8 ± 9.6 years, mean Expanded Disability Status Scale (EDSS) 1.7 ± 1.0). Cognitive functioning was evaluated in the whole sample using Rao’s Brief Repeatable Battery (BRB). Performance on each test was assessed by applying the normative values for the Italian population. In a subgroup of 50 patients, a brain magnetic resonance (MR) study was performed including measurement of T2 lesion volumes (T2LV), neocortical volume (NCV) and normalized brain volume (NBV). The relationship between APOE genotype, CI and MR variables was assessed through univariate and multivariate logistic regression models. CI, most commonly involving complex attention and verbal memory tasks, was found in 28 cases (33%). We identified a total of 19 ε4carriers (22.4%), who did not differ from non-carriers regarding clinical and demographic characteristics. The presence of the ε4 genotype was associated with neither CI (p = 0.28) nor impairment on each neuropsychological test (p > 0.32; corrected for age, gender, disease duration, EDSS, depression and fatigue). The APOE genotype and CI were also not related in the subgroup of younger patients (age < 45 years; p > 0.9). Moreover, CI was related to higher T2LV (p = 0.008) and lower NCV (p = 0.006). In conclusion, in our sample CI was associated with higher subcortical damage and cortical atrophy but not with APOE-ε4 genotype. The role of APOE-ε4 as a possible biomarker in multiple sclerosis is still questionable.

Keywords

multiple sclerosis apolipoprotein E cognitive impairment magnetic resonance

Get full access to this article

View all access options for this article.

References

Amato MP , Zipoli V. , Portaccio E. Cognitive changes in multiple sclerosis. Expert Rev Neurother 2008; 8: 1585-1596.

Amato MP , Ponziani G. , Siracusa G. , Sorbi *S. Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Arch Neurol 2001; 58: 1602-1606.

Siest G. , Pillot T. , Regis-Bailly A. , et al. Apolipoprotein E: An important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41: 1068-1086.

Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer’s disease . Trends Neurosci 1994; 17: 525-530.

Nathan BP , Bellosta S. , Sanan DA , Weisgraber KH , Mahley RW , Pitas RE Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro . Science 1994; 264(5160): 850-852.

Holtzman DM , Fagan AM Potential role of apoE in structural plasticity in the nervous system; implications for disorders of the central nervous system. Trends Cardiovasc Med 1998; 8: 250-255.

Mahley RW , Rall SC, Jr. Apolipoprotein E: Far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1: 507-537.

Strittmatter WJ , Saunders AM , Schmechel D. , et al. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993; 90: 1977-1981.

Bondi MW , Salmon DP , Monsch AU , et al. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology 1995; 45: 2203-2206.

10.

Crawford FC , Vanderploeg RD , Freeman MJ , et al. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology 2002; 58: 1115-1118.

11.

Gambardella A. , Aguglia U. , Chifari R. , et al. ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy. Epilepsia 2005; 46: 110-117.

12.

Burwick RM , Ramsay PP , Haines JL , et al. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: Some answers. Neurology 2006; 66: 1373-1383.

13.

Koutsis G. , Panas M. , Giogkaraki E. , et al. APOE epsilon4 is associated with impaired verbal learning in patients with MS. Neurology 2007; 68: 546-549.

14.

Shi J. , Zhao CB , Vollmer TL , Tyry TM , Kuniyoshi SM APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis. Neurology 2008; 70: 185-190.

15.

Sadovnick AD , Jacobs DH MS and cognition and APOE: The ongoing conundrum about biomarkers. Neurology 2008; 70: 164-165.

16.

Polman CH , Reingold SC , Edan G. , et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘‘McDonald Criteria’’. Ann Neurol 2005; 58: 840-846.

17.

Sorbi S. , Nacmias B. , Forleo P. , et al. ApoE allele frequencies in Italian sporadic and familial Alzheimer’s disease. Neurosci Lett 1994; 177: 100-102.

18.

Kurtzke JF Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452.

19.

Rao SM the Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Milwaukee, WI: Medical College of Wisconsin, 1990.

20.

Barbarotto R. , Laiacona M. , Frosio R. , Vecchio M. , Farinato A. , Capitani E. A normative study on visual reaction times and two Stroop colour-word tests. Ital J Neurol Sci 1998; 19: 161-170.

21.

Montgomery SA , Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.

22.

Amato MP , Portaccio E. , Goretti B. , et al. The Rao’s Brief Repeatable Battery and Stroop Test: Normative values with age, education and gender corrections in an Italian population . Mult Scler 2006; 12: 787-793.

23.

Camp SJ , Stevenson VL , Thompson AJ , et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: A controlled study with MRI correlates. Brain 1999; 122: 1341-1348.

24.

Smith SM , Zhang Y. , Jenkinson M. , et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479-489.

25.

De Stefano N. , Matthews PM , Filippi M. , et al. Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability. Neurology 2003; 60: 1157-1162.

26.

Sicotte NL , Kern KC , Giesser BS , et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008; 131: 1134-1141.

APOE-ε4 is not associated with cognitive impairment in relapsing—remitting multiple sclerosis

Abstract

Keywords

Get full access to this article

References